Found 1 result

Search term: AZD9291 (Found by approved synonym)

ChemSpider 2D Image | Osimertinib | C28H33N7O2

Osimertinib

  • Molecular FormulaC28H33N7O2
  • Average mass499.607 Da
  • Monoisotopic mass499.269562 Da
  • ChemSpider ID31042598

More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

1421373-65-0 [RN]
2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]- [ACD/Index Name]
N-(2-{[2-(Dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino}phenyl)acrylamid [German] [ACD/IUPAC Name]
N-(2-{[2-(Dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino}phenyl)acrylamide [ACD/IUPAC Name]
N-(2-{[2-(Diméthylamino)éthyl](méthyl)amino}-4-méthoxy-5-{[4-(1-méthyl-1H-indol-3-yl)-2-pyrimidinyl]amino}phényl)acrylamide [French] [ACD/IUPAC Name]
osimertinib [Spanish] [INN]
osimertinib [French] [INN]
Osimertinib [INN] [USAN]
osimertinibum [Latin] [INN]
UNII-3C06JJ0Z2O
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

AZD9291 [DBID]
AZD 9291 [DBID]
AZD-9291 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Safety:

      5 Axon Medchem 2342
      H303;H313;H317;H333;H334;H335;H373 Axon Medchem 2342
      no pictogram Axon Medchem 2342
      P101;P102;P103;P260;P262;P263;P264;P270;P280;P304;P312;P340 Axon Medchem 2342
      Warning Axon Medchem 2342
    • Target Organs:

      EGFR inhibitor TargetMol T2490
    • Bio Activity:

      AZD-9291 is a potent and selective mutated forms EGFR inhibitor(Exon 19 deletion EGFR IC50=12.92 nM, L858R/T790M EGFR IC50= 11.44 nM, wild type EGFR IC50= 493.8 nM). MedChem Express HY-15772, http://www.medchemexpress.com/erastin.html
      AZD-9291 is a potent and selective mutated forms EGFR inhibitor(Exon 19 deletion EGFR IC50=12.92 nM, L858R/T790M EGFR IC50= 11.44 nM, wild type EGFR IC50= 493.8 nM). ;IC50 value: 12.92 nM(Exon 19 deletion EGFR); 11.44 nM(L858R/T790M EGFR) [1];Target: L858R/T790M EGFR; Exon 19 deletion EGFRAZD-9291 is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors. AZD9291 is highly active in preclinical models and is well tolerated in animal models. It inhibits both activating and resistant EGFR mutations while sparing the normal form of EGFR that is present in normal skin and gut cells, thereby reducing the side effects encountered with currently available medicines.Patent: WO 2013014448 MedChem Express HY-15772
      EGFR MedChem Express HY-15772
      EGFR TargetMol T2490
      JAK/STAT Signaling MedChem Express HY-15772
      JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; MedChem Express HY-15772
      Tyrosine Kinase/Adaptors TargetMol T2490

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

Density: 1.2±0.1 g/cm3
Boiling Point:
Vapour Pressure:
Enthalpy of Vaporization:
Flash Point:
Index of Refraction: 1.618
Molar Refractivity: 146.6±0.5 cm3
#H bond acceptors: 9
#H bond donors: 2
#Freely Rotating Bonds: 10
#Rule of 5 Violations: 0
ACD/LogP: 3.30
ACD/LogD (pH 5.5): 0.73
ACD/BCF (pH 5.5): 1.00
ACD/KOC (pH 5.5): 2.52
ACD/LogD (pH 7.4): 2.07
ACD/BCF (pH 7.4): 8.86
ACD/KOC (pH 7.4): 55.89
Polar Surface Area: 88 Å2
Polarizability: 58.1±0.5 10-24cm3
Surface Tension: 44.0±7.0 dyne/cm
Molar Volume: 418.4±7.0 cm3

Click to predict properties on the Chemicalize site





Feedback Form